Report cover image

Antiparasitic Drugs Market, by Product Type (Anthelmintics (Anticestodal Drugs, Antitrematodal Drugs, Antinematodal Drugs), Antiprotozoal Agents (Antimalarials Agents, Antibabesial Agents, Antiamoebic Agents, Others), Ectoparasiticide (Antiscabietic Agent

Publisher Coherent Market Insights
Published Aug 29, 2022
Length 160 Pages
SKU # CMI17440692

Description

Antiparasitic Drugs Market, by Product Type (Anthelmintics (Anticestodal Drugs, Antitrematodal Drugs, Antinematodal Drugs), Antiprotozoal Agents (Antimalarials Agents, Antibabesial Agents, Antiamoebic Agents, Others), Ectoparasiticide (Antiscabietic Agents, Pediculicides)), by Route of Administration (Oral, Injectable, Topical), by Application (Human Health, Animal Health, Crop Health), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Antiparasitic drugs treat parasitic infections. These infections result from parasites, which are tiny organisms that live on or inside people and animals. There are various antiparasitic drugs, each drug targets a specific parasite.

Antiparasitic drugs treat several kinds of infections that result from a thousand types of parasites. Three main types of parasites which can make people sick are, Ectoparasites, Helminths, and Protozoas, which are treated with antiparasitic drugs such as anticestodal drugs, antitrematodal drugs, antinematodal drugs, antimalarials agents, antibabesial agents, antiamoebic agents, trypanocidal agents, antileishmanial agents, antiscabietic agents, and pediculicides.

Market Dynamics

Governments of various countries, non-profit organizations, and some market players such as Novartis, etc. are involved in initiatives and campaigns to increase the widespread use of antiparasitic drugs and improve the treatment of tropical diseases including parasitic illness such as malaria, leishmaniasis, Chagas disease, etc. This would in turn increase demand for antiparasitic drugs and hence fuel growth of the global antiparasitic drugs market over the forecast period.

For instance, in October 2021, The President's Malaria Initiative (PMI) of the U. S. launched a new five-year strategy, ‘End Malaria Faster’, with the goal of eliminating malaria within a generation, contributing to global targets of saving more than 4 million lives and averting 1 billion cases by 2025. The five-year PMI strategy seeks to reduce health inequities, improve disease surveillance, and continue to save lives.

Key features of the study:
  • This report provides in-depth analysis of the global antiparasitic drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global antiparasitic drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Merck KGaA, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd, Cipla Limited, Cadila Pharmaceuticals, Watson International Limited, Vivaldis, Glenmark Pharmaceuticals Limited, Viatris Inc., Novartis AG, AdvaCare Pharma, Lupin, Sun Pharmaceutical Industries Ltd., and Aurobindo Pharma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global antiparasitic drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antiparasitic drugs market
Detailed Segmentation:
  • Global Antiparasitic Drugs Market, By Product Type:
  • Anthelmintics
  • Anticestodal Drugs
  • Antitrematodal Drugs
  • Antinematodal Drugs
  • Antiprotozoal Agents
  • Antimalarials Agents
  • Antibabesial Agents
  • Antiamoebic Agents
  • Others (Trypanocidal Agents, Antileishmanial Agents, etc.)
  • Ectoparasiticide
  • Antiscabietic Agents
  • Pediculicides
  • Global Antiparasitic Drugs Market, By Route of Administration:
  • Oral
  • Injectable
  • Topical
  • Global Antiparasitic Drugs Market, By Application:
  • Human Health
  • Animal Health
  • Crop Health
  • Global Antiparasitic Drugs Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Merck KGaA.*
  • Company Overview
  • Material Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • GlaxoSmithKline plc
  • Dr. Reddy’s Laboratories Ltd
  • Cipla Limited
  • Cadila Pharmaceuticals
  • Watson International Limited
  • Vivaldis
  • Glenmark Pharmaceuticals Limited
  • Viatris Inc.
  • Novartis AG
  • AdvaCare Pharma
  • Lupin
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

160 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Route of Administration
Market Snippet, By Application
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Pipeline Analysis
PEST Analysis
Regulatory Scenario
Market Trends
Key Highlights
Mergers & Acquisitions
4. Global Antiparasitic Drugs Market – Impact of Coronavirus (Covid-19) Pandemic
Economic Impact
Impact on Clinical Trials
Government Initiatives
5. Global Antiparasitic Drugs Market, By Product Type, 2017 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Anthelmintics
Anticestodal Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Antitrematodal Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Antinematodal Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Antiprotozoal Agents
Antimalarials Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Antibabesial Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Antiamoebic Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Others (Trypanocidal Agents, Antileishmanial Agents, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Ectoparasiticide
Antiscabietic Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Pediculicides
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
6. Global Antiparasitic Drugs Market, By Route of Administration, 2017 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
7. Global Antiparasitic Drugs Market, By Application, 2017 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Human Health
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Animal Health
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Crop health
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
8. Global Antiparasitic Drugs Market, By Region, 2017 – 2030, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2022 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2030
North America
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
South Africa
Central Africa
North Africa
9. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Merck KGaA
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
GlaxoSmithKline plc
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Dr. Reddy’s Laboratories Ltd
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Cipla Limited
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Cadila Pharmaceuticals
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Watson International Limited
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Vivaldis
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Glenmark Pharmaceuticals Limited
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Viatris Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Novartis AG
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
AdvaCare Pharma
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Lupin
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Sun Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Aurobindo Pharma
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
10. Section
References
Research Methodology
About us and Sales Contact
*Browse 53 market data tables and 38 figures on "Antiparasitic Drugs Market” - Global forecast to 2030.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us